Nate Demars

Corporate Officer/Principal at AKTIS ONCOLOGY, INC.

Health Technology

Consumer Services

Profile

Nate Demars is Vice President & Head-Clinical Operations at Aktis Oncology, Inc. since 2024.
Former roles include Senior Director-Clinical Operations at Alaunos Therapeutics, Inc. and Senior Director-Clinical Operations at Neogene Therapeutics, Inc. Education includes graduate studies at the University of Connecticut and undergraduate studies at the University of New Hampshire.

Nate Demars active positions

Companies	Position	Start
AKTIS ONCOLOGY, INC.	Corporate Officer/Principal	2024-08-31

All active positions of Nate Demars

Former positions of Nate Demars

Companies	Position	End
ALAUNOS THERAPEUTICS, INC.	Corporate Officer/Principal	-
Neogene Therapeutics, Inc. Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers	Corporate Officer/Principal	-

See the detail of Nate Demars's experience

Training of Nate Demars

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nate Demars's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Connecticut University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of New Hampshire University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alaunos Therapeutics, Inc. Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies	Health Technology
Neogene Therapeutics, Inc. Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers	Health Technology
Aktis Oncology, Inc. Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers	Health Technology